Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.18 - $10.91 $94,865 - $325,467
29,832 New
29,832 $324,000
Q4 2021

Feb 14, 2022

BUY
$10.38 - $15.2 $176,885 - $259,023
17,041 Added 103.56%
33,496 $376,000
Q3 2021

Nov 15, 2021

SELL
$13.6 - $17.88 $90,848 - $119,438
-6,680 Reduced 28.87%
16,455 $241,000
Q1 2021

May 17, 2021

BUY
$19.16 - $28.09 $107,334 - $157,360
5,602 Added 31.95%
23,135 $466,000
Q4 2020

Feb 16, 2021

BUY
$16.4 - $22.9 $287,541 - $401,505
17,533 New
17,533 $360,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $146M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.